TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
In Chronic Renal Failure (CRF) patients with primary glomerular disease or nephrosclerosis as the primary disease: * To confirm the superiority of TRK-100STP over placebo * To determine the recommended therapeutic dose in the 2 doses of TRK-100STP * To assess the safety of TRK-100STP
Epistemonikos ID: 6a586e0fb3066d32335ed4ec59ba3c34bb946fec
First added on: May 05, 2024